Peering Into Moderna's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Moderna's (NYSE:MRNA) short interest has increased by 14.18% since the last report, with 22.38 million shares sold short, representing 7.81% of available shares. It would take approximately 3.96 days to cover these short positions based on current trading volume. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop. Moderna has a higher short interest than its peer group average of 4.93%.
December 04, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Moderna's increased short interest suggests bearish market sentiment, but it's not a definitive predictor of immediate stock price decline. The stock has more short interest compared to its peers, which could lead to increased volatility.
While the rise in short interest for Moderna indicates a bearish outlook from traders, it doesn't necessarily mean the stock price will fall in the short term. High short interest can sometimes lead to a short squeeze if the stock price starts to rise, which can cause rapid price increases. However, the impact is uncertain and depends on broader market conditions and company performance.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100